Showing 1 - 20 results of 50,667 for search '(( 59 ((mean decrease) OR (_ decrease)) ) OR ((( 12 nn decrease ) OR ( _ can decrease ))))*', query time: 0.64s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Data_Sheet_1_Perceptual Priming Can Increase or Decrease With Aging.PDF by Kalathupiriyan A. Zhivago (9659504)

    Published 2020
    “…Thus, perceptual priming can increase or decrease with age or cognitive impairment, but these changes do not covary with explicit memory.…”
  9. 9
  10. 10

    SU9518 decreases cell proliferation and restore normal remodeling in eNOS (−/−) mice. by Jun Yu (5904)

    Published 2012
    “…(B) Representative hematoxylin and eosin stained LC cross sections of vehicle or SU9518 treated mice. Inward remodeling can be seen in SU9518 treated LC. Scale bar represents 100 µm. …”
  11. 11
  12. 12

    Adding tsetse control to medical activities contributes to decreasing transmission of sleeping sickness in the Mandoul focus (Chad) by Mahamat Hissene Mahamat (4282306)

    Published 2017
    “…The catch of tsetse from 44 sentinel biconical traps declined after target deployment with only five tsetse being caught in nine surveys giving a mean catch of 0.005 tsetse/trap/day. Modelling indicates that 70.4% (95% CI: 51–95%) of the reduction in reported cases between 2013 and 2015 can be attributed to vector control with the rest due to medical intervention. …”
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Baseline characteristics of study participants. by Zixia Qian (21474969)

    Published 2025
    “…For each age group, the mumps IgG seroprevalence rates were 74.40%, 89.02%, 85.58%, 68.60%, 69.28%, 78.42%, and 80.63% for those <8 months, 8 months-2 years, 3–5 years, 6–17 years, 18–39 years, 40–59 years, and>=60 years, respectively. In terms of the percentage decreases in anti-mumps antibody titers, in the population receiving the 1-dose vaccine, there was a mean decrease of 2.06% per year. …”
  20. 20

    The numerical data used in this study. by Zixia Qian (21474969)

    Published 2025
    “…For each age group, the mumps IgG seroprevalence rates were 74.40%, 89.02%, 85.58%, 68.60%, 69.28%, 78.42%, and 80.63% for those <8 months, 8 months-2 years, 3–5 years, 6–17 years, 18–39 years, 40–59 years, and>=60 years, respectively. In terms of the percentage decreases in anti-mumps antibody titers, in the population receiving the 1-dose vaccine, there was a mean decrease of 2.06% per year. …”